GIVE LIFE TIME LIMITED

Sales & Support
Request A Quote - Email

Select Language

English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Hindi
Turkish
Indonesian
Vietnamese
Thai
Bengali
Persian
Polish

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Shopping

Categories: All Categories

Chest Lung Cancer Drugs

Breast Cancer Drugs

Gastrointestinal Cancer Treatment

Blood Myeloma Lymphoma Drugs

Hepatobiliary Cancer Cirrhosis Hepatitis C Drugs

Pancreatic Cancer Drugs

Urogenital Cancer Drugs

Thrombocytopenia Treatment Drugs

Skin Endocrine Rheumatism Drugs

Genetic Testing Services

Genetic Testing Equipment

Medical Diagnostic Test Kits

Medical Rescue Drone

Home Products Chest Lung Cancer Drugs

NOVARTIS Capmatinib INC280 Tabrecta 150mg*56 tablets for stage 1 2 3 lung cancer Non-small cell lung cancer

All Products

Chest Lung Cancer Drugs (58)

Breast Cancer Drugs (18)

Gastrointestinal Cancer Treatment (11)

Blood Myeloma Lymphoma Drugs (23)

Hepatobiliary Cancer Cirrhosis Hepatitis C Drugs (17)

Pancreatic Cancer Drugs (1)

Urogenital Cancer Drugs (17)

Thrombocytopenia Treatment Drugs (8)

Skin Endocrine Rheumatism Drugs (9)

Genetic Testing Services (52)

Genetic Testing Equipment (3)

Medical Diagnostic Test Kits (8)

Medical Rescue Drone (7)

I'm Online Chat Now

Certification

NOVARTIS Capmatinib INC280 Tabrecta 150mg*56 tablets for stage 1 2 3 lung cancer Non-small cell lung cancer

Large Image : NOVARTIS Capmatinib INC280 Tabrecta 150mg*56 tablets for stage 1 2 3 lung cancer Non-small cell lung cancer Get Best Price

Product Details:

Place of Origin:	Switzerland
Brand Name:	Capmatinib
Model Number:	INC280

Payment & Shipping Terms:

Minimum Order Quantity:	1 PCS
Price:	Please contact a specialist WhatsApp：55342706
Packaging Details:	Negotiable
Delivery Time:	Negotiable
Payment Terms:	Western Union, MoneyGram, T/T
Supply Ability:	Negotiable

Contact Now

Detailed Product Description

Specifications::	150mg56 Tablets/box; 200mg56 Tablets/box	Indications:	Non-small Cell Lung Cancer
Target:	MET	Product Name:	Capmatinib/Capmatinib
Recommended Dose:	Please Follow Doctor's Advice	Storage:	Dispense Original Packaging With Desiccant Box. Store Within The Temperature Range 20°C To 25°C (68°F To 77°F), With An Allowed Excursion Between 15°C And 30°C (59°F And 86°F), Protected From Moisture. Discard Any Remaining Unused Capmatinib 6 Weeks Afte

Dosage Form
Tablets:

150 mg: light orange-brown, oval, curved film-coated with beveled edges, no score, debossed with "DU" on one side and "NVR" on the other side

200 mg: yellow, oval, curved film-coated with beveled edges, no score, debossed with "LO" on one side and "NVR" on the other side

Dispense original packaging with desiccant cartridge. Store at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from moisture. Discard any remaining unused TABRECTA 6 weeks after first opening the bottle.

Indications
Tabrecta (capmatinib) is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors harbor a MET exon 14 skipping (METEX 14) mutation.

Tag:

Contact Person: Roy

Tel: 13313517590

Send your inquiry directly to us

More Chest Lung Cancer Drugs